The Clinical Update presents an excellent opportunity for clinicians to learn the latest about the clinical management of osteoporosis and fracture risk prevention. Leading experts in the field will provide state-of-the-art lectures covering a wide variety of clinically important topics. If you are a clinician working in the bone field, you should not miss this amazing opportunity to be up to speed with the latest, which you might have missed. We all know how time-demanding the sheer clinical work is. Join us for the ECTS 2018 in Valencia and you will hear about:
- The diagnostic work-up needed to identify causes of secondary osteoporosis. What evaluation should be done to detect the most common causes of secondary osteoporosis?
- Identifying vertebral fractures with Vertebral Fracture Assessment (VFA) by lateral DXA and how to incorporate presence of these fractures into the over-all fracture risk. Is VFA indicated in clinical practice and what are the benefits and potential risks associated with VFA-use in the clinic?
- The comprehensive evaluation of clinical risk factor needed to determine fracture risk and identify treatment thresholds. Which risk factors are relevant to consider, how does one combine them and at what risk is an intervention motivated?
- The evidence for prevention of non vertebral fractures with medication and non-pharmacological measures. Are osteoporosis medications and/or fall preventive measures really able to reduce the risk of these fractures?
- The benefit of using osteoporosis medications to prevent fractures in the oldest old. Is there sufficient evidence to recommend pharmacological treatment in this patient group and do the positive effects of treatment outweigh the risk of side effects?
- The effects of glucocorticoid treatment on the skeleton and fracture risk. Which of these patients should be evaluated, in terms of risk factor analyses and bone densitometry, and given osteoporosis medications?
- The clinical implications and management of primary hyperparathyroidism. What is the optimal treatment course to prevent bone loss and fractures in these patients?
- The clinical value of calcium and vitamin D supplementation. When and why it may or may not be useful?
- The clinical spectrum of renal osteodystrophy. How common is it? How to diagnose and manage it?
- Paget’s disease of bone: recent insights into the changing epidemiology and therapeutic approaches.
- Drug-induced osteoporosis: when and how to detect it, how to handle it.